DOB-NDEPA
Pharmaceutical compound
From Wikipedia, the free encyclopedia
DOB-NDEPA is a chemical compound of the phenethylamine, DOx, and NDEPA families.[1] It is the N-(N,N-diethylpropylamide) (NDEPA) derivative of the psychedelic drug DOB.[1] The drug can also be thought of as a derivative of DOB with an LSD-like N,N-diethylamide moiety.[1] A quantitative structure–activity relationship (QSAR) predicted that DOB-NDEPA would bind with high affinity to the serotonin 5-HT2A receptor.[1] Its predicted affinity (Ki) was 4.6 nM.[1] DOB-NDEPA was first described in the scientific literature by 1999.[1]
| |
| Clinical data | |
|---|---|
| Other names | NDEPA-DOB; "Compound ko2"[1] |
| Drug class | Possible serotonin 5-HT2A receptor modulator[1] |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| Chemical and physical data | |
| Formula | C18H29BrN2O3 |
| Molar mass | 401.345 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
